1 / 15

Neurofibromatosis 1 associated pain syndromes

Neurofibromatosis 1 associated pain syndromes. Thomas J Geller, MD NF clinic director, CGCH Assoc Prof Neurology, SLU. Frequency of Pain as a complaint in Neurofibromatosis patients.

tevin
Download Presentation

Neurofibromatosis 1 associated pain syndromes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Neurofibromatosis 1 associated pain syndromes Thomas J Geller, MD NF clinic director, CGCH Assoc Prof Neurology, SLU

  2. Frequency of Pain as a complaint in Neurofibromatosis patients • Though numerous neurologic complications of NF-1 appear (optic gliomas, subcutaneous neurofibromas, macrocephaly, plexiform neurofibromas, seizures, LD’s), the most common symptoms causing disability for adult patients are pain symptoms. (11.3 % in Zeller’s 1 year study of 158 adults)

  3. Headache studies in NF-1 • North reports an incidence of 9% of severe headache. • Zeller found adult incidence of disabling headache to be 18%, but did not break out the patients with common migraine. • Recurring headache in DiMaurio’s study occurred in 46% of NF patients; 14% met criteria for migraine, 18% tension headache. • Other studies show that migraine incidence in the general population is about 18%, regardless of severity.

  4. Age and Pain in NF-1

  5. Quality of life with painful complications of NF-1 • French dermatology study of mixed adult/ ped NF-1 demonstrated that for all aspects of the general questionnaire, including bodily pain, pts with NF-1 reported lower QOL scores than the general population. • Increased severity of the disease was assoc with increased negative effect on bodily pain.

  6. Pediatric NF Pain study • Oostenbrink studied 34 NF Dutch children from 1 to 6 yrs of age using the infant/toddler QOL index. • Added 7 questions on pain and limitations of activity • A significant difference in QOL was identified from kids with bodily pain vs those without bodily pain.

  7. Non-headache pain: (bodily pain) • In the 18 adults with chronic pain, symptoms began in childhood in 7. • Pain was felt to be clearly organic in 83%. • In 17% the cause was unknown.

  8. Causes of peripheral pain • Peripheral nerve or root- 39% • Surgical pain- 22% • Malignant peripheral nerve sheath tumor-17% • plexiform neurofibroma- 11% • Subcutaneous neurofibroma-11%

  9. Outcome of peripheral pain in NF-1 • 77% were able to achieve at least partial remission of pain. • Pain was intermittent in ½ of patients. • Chronic pain was complicated by “breakthru” with movement or contact of the affected nerve region in most patients. • Optimal pain management was considered to be analgesics, antidepressants and/or anticonvulsants. Some required neuro-stimulation or spinal procedures.

  10. Theoretical mechanisms of pain supersensitivity in NF-1 • Changes in the excitability of dorsal root entering the spinal cord • Study of sensory cultured neurons reveals enhanced excitability of neurons, and increased release of pain neurotransmitters CGRP and substance P. • Anxiety in the subject over the risk of pain being associated with a malignancy

  11. Neuropathic May be caused by several processes • Direct tumor infiltration • Nerve damage / demyelination • Nerve compression • Radiation • Chemotherapy (taxols & vincristine) • Viral • Metabolic

  12. Spontaneous burning Intermittent Radiating Shooting Light touch (allodynia) Sharp Stabbing Pins & needles Neuropathic

  13. Neuropathic pain mechanisms

  14. Cornerstones of treatment of neuropathic pain • Because neuropathic pain has both peripheral and central mechanisms of development and enhancement, treatment is probably best when multiple methods of attack are applied. • Treatment should be applied early to avoid “wind-up” mechanisms of enhanced pain

  15. Agents for neuropathic pain • Analgesics including opioids when needed • Ketotifen for neurofibromas (esp with itching) • Calcium channel blocking anticonvulsants, (Neurontin and Lyrica) • Norepinephrine and serotonin blockers, (tricyclics and Cymbalta) • Possibly sodium channel blockers • PHYSIOTHERAPY • Relaxation therapies • Surgical management

More Related